Non-ST segment elevation myocardial infarction in a patient with COVID-19
Coronavirus disease 2019 (COVID-19) is associated with a wide spectrum of cardiovascular (CV) manifestations. Primary cardiac manifestations of COVID-19 disease include acute coronary syndrome (ACS), myocarditis, and arrhythmias. Secondary cardiac involvement is usually due to a systemic inflammator...
Main Authors: | Fahmi Othman, Abdul Rehman Abid, Mohammad Alibrahim, Sabir Abdulkarim, Mohammed A Abdelaty, Mohamed Aboukamar, Salah Arafah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Heart Views |
Subjects: | |
Online Access: | http://www.heartviews.org/article.asp?issn=1995-705X;year=2020;volume=21;issue=3;spage=215;epage=219;aulast=Othman |
Similar Items
-
ST-segment resolution as a marker for severe myocardial fibrosis in ST-segment elevation myocardial infarction
by: Qian Dong, et al.
Published: (2021-09-01) -
THE RELEVANCE OF THROMBOLYTIC THERAPY IN ST ELEVATION MYOCARDIAL INFARCTION
by: N. V. Teplova, et al.
Published: (2014-05-01) -
What is new in 2017 European Society of Cardiology ST Elevation Myocardial Infarction guideline?
by: Aylin Yıldırır
Published: (2017-10-01) -
Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
by: Gao L, et al.
Published: (2014-07-01) -
No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
by: Sanjiv Gupta, et al.
Published: (2016-07-01)